Cas:1119390-95-2 4-(4-Fluorophenyl)-3-methyl-1H-pyrazol-5-amine manufacturer & supplier

Chemical Name:4-(4-Fluorophenyl)-3-methyl-1H-pyrazol-5-amine

CAS.NO:1119390-95-2

Synonyms:4-(4-Fluorophenyl)-3-methyl-1H-pyrazol-5-amine

Molecular Formula:C₁₀H₁₀FN₃

Molecular Weight:191.20500

HS Code:2933199090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:54.70000

Exact Mass:191.08600

LogP:2.68760

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 4-(4-Fluorophenyl)-3-methyl-1H-pyrazol-5-amine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,4-(4-Fluorophenyl)-3-methyl-1H-pyrazol-5-amine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4-(4-Fluorophenyl)-3-methyl-1H-pyrazol-5-amine Use and application,4-(4-Fluorophenyl)-3-methyl-1H-pyrazol-5-amine technical grade,usp/ep/jp grade.

Related News: As proof-of-principle for the unique advantages arising from selecting a single engineered iPSC clone for the production of CAR T-cell therapy, the scientists assessed 747 clones after engineering a pool of cells using CRISPR. It was found that only about 2% of clones met the Company��s standards for overall quality including containing both bi-allelic disruption of the TCR, proper insertion of the CAR into the TRAC locus without random transgene integrations, and no evidence of off-target genomic modifications or translocations. 4-(4-Fluorophenyl)-3-methyl-1H-pyrazol-5-amine manufacturer INSPIRE is a global, multi-center, randomized, controlled study to assess the efficacy and safety of IV rigosertib in higher-risk MDS (HR-MDS) patients who had progressed on, failed to respond to, or relapsed after previous treatment with a hypomethylating agent (HMA) within nine cycles over the course of one year after initiation of HMA treatment. 4-(4-Fluorophenyl)-3-methyl-1H-pyrazol-5-amine supplier Beijing will strengthen its monitoring of overseas drug market and collect global prices for imported medicines, Friday��s guideline said. 4-(4-Fluorophenyl)-3-methyl-1H-pyrazol-5-amine vendor INSPIRE is a global, multi-center, randomized, controlled study to assess the efficacy and safety of IV rigosertib in higher-risk MDS (HR-MDS) patients who had progressed on, failed to respond to, or relapsed after previous treatment with a hypomethylating agent (HMA) within nine cycles over the course of one year after initiation of HMA treatment. 4-(4-Fluorophenyl)-3-methyl-1H-pyrazol-5-amine factory Beijing will strengthen its monitoring of overseas drug market and collect global prices for imported medicines, Friday��s guideline said.